$18.99
-0.89%Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
No Operating Cash Flow Data
HQH has not reported any operating cash flow values in the available annual periods.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Outstanding operational efficiency. The company generates substantial profit from core operations.
Exceptional profitability. The company converts a significant portion of revenue to bottom-line earnings.
Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.
Exceptional profitability across all levels: Strong pricing power, efficient operations, and healthy bottom line indicate a high-quality business with sustainable competitive advantages.
HQH • NYSE
| Abrdn Healthcare Investors Income Statement | Dec 2025 | Sep 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||||||
99.8M | 99.8M | 10.8M | 10.3M | 8.3M | 6.5M | 8.9M | 7.6M | 6.8M | 5.6M | 4.8M | 4.3M | 2.1M | |
GROSS PROFIT | |||||||||||||
99.8M | 99.8M | 10.8M | 10.3M | 8.3M | 6.5M | 8.9M | 7.6M | 6.8M | 5.6M | 4.8M | 4.3M | 2.1M | |
OPERATING INCOME | |||||||||||||
(1.2M) | (1.2M) | (11M) | (11.5M) | (11.9M) | (12.7M) | (10.9M) | (10.5M) | (10.9M) | (10.8M) | (11.1M) | (12.2M) | (9.3M) | |
(1.1M) | (1.1M) | (11M) | (11.5M) | (11.9M) | (12.7M) | (10.9M) | (10.5M) | (10.9M) | (10.8M) | (11.1M) | (12.2M) | (9.3M) | |
98.6M | 98.6M | -220.3K | -1.2M | -3.7M | -6.2M | -2M | -2.9M | -4.1M | -5.2M | -6.3M | -7.9M | -7.2M | |
PRE-TAX INCOME | |||||||||||||
1M | 1M | 2M | 620K | 112.3K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
(55.7K) | (55.7K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | 0.0 | 185.2M | 57.5M | -190.6M | 161.4M | 243.2M | -142.4M | 73.3M | 126.4M | -49.7M | 104M | 229.2M | |
98.6M | 98.6M | 184.9M | 56.3M | -194.2M | 155.2M | 241.2M | -145.3M | 69.2M | 121.3M | -56M | 96.2M | 222M | |
NET INCOME | |||||||||||||
98.6M | 98.6M | 184.9M | 56.3M | -194.2M | 155.2M | 241.2M | -145.3M | 69.2M | 121.3M | -56M | 96.2M | 222M |
HQH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 07, 2026 | May 27, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 14, 2025 | May 28, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 22, 2024 | June 25, 2024 | 2024 | |
8-K 8-K 2023 N/A | September 12, 2023 | September 06, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | July 10, 2023 | August 14, 2023 | 2023 | |
DEF 14A DEF 14A N/A | April 11, 2023 | April 11, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 12, 2022 | June 09, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 13, 2021 | June 10, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 14, 2020 | June 11, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 15, 2019 | June 13, 2019 | 2019 |
Continue your HQH research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.